A low dose cell therapy system for treating osteoarthritis: In vivo study and in vitro mechanistic investigations

Mesenchymal stem cells (MSCs) can be effective in alleviating the progression of osteoarthritis (OA). However, low MSC retention and survival at the injection site frequently require high doses of cells and/or repeated injections, which are not economically viable and create additional risks of comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Liu, Wei, Li, Jiao Jiao, Chai, Senlin, Xing, Dan, Yu, Hongsheng, Zhang, Yuanyuan, Yan, Wenjin, Xu, Zhihong, Zhao, Bin, Du, Yanan, Jiang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379370/
https://www.ncbi.nlm.nih.gov/pubmed/34466747
http://dx.doi.org/10.1016/j.bioactmat.2021.05.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379370/
https://www.ncbi.nlm.nih.gov/pubmed/34466747
http://dx.doi.org/10.1016/j.bioactmat.2021.05.029

Ejemplares similares